From: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase
Number
Percent
NSLNs Examined
Median (range)
15 (11–52)
N° of positive NSLNs
610
40.8
2 (1–41)
N° of Copies (Highest copy number)
≤ 1500
305
20.4
> 1500–12,000
329
22.0
> 12,000–111,000
460
30.8
> 111,000
401
26.8